- $919.13m
- $1.35bn
- $397.58m
- 70
- 58
- 23
- 49
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 309 | 270 | 336 | 404 | 398 |
Cost of Revenue | |||||
Gross Profit | 215 | 185 | 234 | 268 | 265 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 270 | 193 | 299 | 262 | 276 |
Operating Profit | 38.6 | 76.4 | 36.7 | 142 | 122 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -87.9 | -48.7 | -30.6 | 106 | 97.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -88.5 | -48.6 | 157 | 92.1 | 146 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -146 | -250 | 153 | 92.1 | 146 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -146 | -250 | 153 | 92.1 | 146 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.618 | -0.59 | 1.67 | 0.687 | 1.1 |